<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>Characteristics of products authorised with and without aRMMs</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left"/>
    <th align="left">Total</th>
    <th align="left">Products without aRMMs at approval</th>
    <th align="left">Products with introduced aRMMs</th>
    <th align="left">Products with aRMMs at approval</th>
    <th align="left">Products with discontinued aRMMs</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">Number of products</td>
    <td align="left">476</td>
    <td align="left">346</td>
    <td align="left">14</td>
    <td align="left">130</td>
    <td align="left">4</td>
   </tr>
   <tr>
    <td align="left">Median follow-up time in months (range)</td>
    <td align="left">60 (8–150)</td>
    <td align="left">58 (8–150)</td>
    <td align="left">43 (17–137)</td>
    <td align="left">65 (8–150)</td>
    <td align="left">90 (25–96)</td>
   </tr>
   <tr>
    <td align="left">Type of MA (
     <italic>N</italic>, %)
    </td>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Regular MA</td>
    <td align="left">431 (91)</td>
    <td align="left">320 (92)</td>
    <td align="left">13 (93)</td>
    <td align="left">111 (85)</td>
    <td align="left">4 (100)</td>
   </tr>
   <tr>
    <td align="left">Conditional MA</td>
    <td align="left">20 (4)</td>
    <td align="left">12 (3)</td>
    <td align="left">0</td>
    <td align="left">8 (6)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">MA under exceptional circumstances</td>
    <td align="left">25 (5)</td>
    <td align="left">14 (4)</td>
    <td align="left">1 (7)</td>
    <td align="left">11 (8)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Orphan designation** (yes) (
     <italic>N</italic>, %)
    </td>
    <td align="left">86 (18)</td>
    <td align="left">54 (16)</td>
    <td align="left">1 (7)</td>
    <td align="left">32 (25)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">ATC group (
     <italic>N</italic>, %)
    </td>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Alimentary tract and metabolism (A)</td>
    <td align="left">57 (12)</td>
    <td align="left">47 (14)</td>
    <td align="left">1 (7)</td>
    <td align="left">10 (8)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Blood and blood forming organs (B)</td>
    <td align="left">38 (8)</td>
    <td align="left">25 (7)</td>
    <td align="left">5 (36)</td>
    <td align="left">13 (10)</td>
    <td align="left">1 (25)</td>
   </tr>
   <tr>
    <td align="left">Cardiovascular system (C)</td>
    <td align="left">25 (5)</td>
    <td align="left">15 (4)</td>
    <td align="left">0</td>
    <td align="left">10 (8)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Dermatologicals (D)</td>
    <td align="left">7 (1)</td>
    <td align="left">5 (1)</td>
    <td align="left">0</td>
    <td align="left">2 (2)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Genitourinary tract (G)</td>
    <td align="left">15 (3)</td>
    <td align="left">12 (3)</td>
    <td align="left">0</td>
    <td align="left">3 (2)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Hormones for systemic use (H)</td>
    <td align="left">6 (1)</td>
    <td align="left">5 (1)</td>
    <td align="left">0</td>
    <td align="left">1 (1)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Antiinfectives for systemic use (J)</td>
    <td align="left">91 (19)</td>
    <td align="left">77 (22)</td>
    <td align="left">3 (21)</td>
    <td align="left">14 (11)</td>
    <td align="left">1 (25)</td>
   </tr>
   <tr>
    <td align="left">Antineoplastic and immunomodulatory agents (L)</td>
    <td align="left">129 (27)</td>
    <td align="left">82 (24)</td>
    <td align="left">1 (7)</td>
    <td align="left">47 (36)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Musculoskeletal system (M)</td>
    <td align="left">13 (3)</td>
    <td align="left">9 (3)</td>
    <td align="left">2 (14)</td>
    <td align="left">4 (3)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Nervous system (N)</td>
    <td align="left">37 (8)</td>
    <td align="left">29 (8)</td>
    <td align="left">1 (7)</td>
    <td align="left">8 (6)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Antiparasitic drugs (P)</td>
    <td align="left">1 (0.2)</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td align="left">1 (1)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Respiratory system (R)</td>
    <td align="left">16 (3)</td>
    <td align="left">13 (4)</td>
    <td align="left">0</td>
    <td align="left">3 (2)</td>
    <td align="left">1 (25)</td>
   </tr>
   <tr>
    <td align="left">Sensory organs (S)</td>
    <td align="left">16 (3)</td>
    <td align="left">10 (3)</td>
    <td align="left">0</td>
    <td align="left">6 (5)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Various (V)</td>
    <td align="left">25 (5)</td>
    <td align="left">17 (5)</td>
    <td align="left">1 (7)</td>
    <td align="left">8 (6)</td>
    <td align="left">1 (25)</td>
   </tr>
   <tr>
    <td align="left">Type of aRMMs (
     <italic>N</italic>, %)
    </td>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Educational materials for HCP</td>
    <td align="left"/>
    <td align="left"/>
    <td align="left">12 (86)</td>
    <td align="left">122 (94)</td>
    <td align="left">4 (100)</td>
   </tr>
   <tr>
    <td align="left">Educational materials for patients/caregivers</td>
    <td align="left"/>
    <td align="left"/>
    <td align="left">7 (50)</td>
    <td align="left">72 (55)</td>
    <td align="left">2 (50)</td>
   </tr>
   <tr>
    <td align="left">Controlled access</td>
    <td align="left"/>
    <td align="left"/>
    <td align="left">0</td>
    <td align="left">7 (5)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Controlled distribution</td>
    <td align="left"/>
    <td align="left"/>
    <td align="left">2 (14)</td>
    <td align="left">6 (5)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Pregnancy prevention programme</td>
    <td align="left"/>
    <td align="left"/>
    <td align="left">0</td>
    <td align="left">8 (6)</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Authorisation status* (
     <italic>N</italic>, %)
    </td>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Authorised</td>
    <td align="left">433 (91)</td>
    <td align="left">316 (91)</td>
    <td align="left">11 (79)</td>
    <td align="left">117 (90)</td>
    <td align="left">4 (100)</td>
   </tr>
   <tr>
    <td align="left">Suspended</td>
    <td align="left">1 (0.2)</td>
    <td align="left">1 (0.3)</td>
    <td align="left">0</td>
    <td align="left">0</td>
    <td align="left">0</td>
   </tr>
   <tr>
    <td align="left">Withdrawn</td>
    <td align="left">42 (9)</td>
    <td align="left">29 (8)</td>
    <td align="left">3 (21)</td>
    <td align="left">13 (10)</td>
    <td align="left">0</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>aRMMs</italic> additional risk minimisation measures, 
   <italic>ATC</italic> Anatomical Therapeutic Chemical, 
   <italic>HCP</italic> healthcare professionals, 
   <italic>MA</italic> marketing authorisation
  </p>
  <p>*At time of data collection (1 July 2018)</p>
  <p>**Statistically significant difference between products without aRMMs at approval and products with aRMMs at approval</p>
 </table-wrap-foot>
</table-wrap>
